Immage Biotherapeutics Corp Stock Market Value
| IMMG Stock | USD 0.0001 0.00 0.00% |
| Symbol | Immage |
Immage Biotherapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immage Biotherapeutics. If investors know Immage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immage Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immage Biotherapeutics is measured differently than its book value, which is the value of Immage that is recorded on the company's balance sheet. Investors also form their own opinion of Immage Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Immage Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immage Biotherapeutics' market value can be influenced by many factors that don't directly affect Immage Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immage Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immage Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immage Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immage Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immage Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immage Biotherapeutics.
| 10/28/2025 |
| 12/27/2025 |
If you would invest 0.00 in Immage Biotherapeutics on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Immage Biotherapeutics Corp or generate 0.0% return on investment in Immage Biotherapeutics over 60 days. Immage Biotherapeutics Corp. does not have significant business operations More
Immage Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immage Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immage Biotherapeutics Corp upside and downside potential and time the market with a certain degree of confidence.
Immage Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immage Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immage Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Immage Biotherapeutics historical prices to predict the future Immage Biotherapeutics' volatility.Immage Biotherapeutics Backtested Returns
We have found three technical indicators for Immage Biotherapeutics, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Immage Biotherapeutics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Immage Biotherapeutics Corp has no correlation between past and present. Overlapping area represents the amount of predictability between Immage Biotherapeutics time series from 28th of October 2025 to 27th of November 2025 and 27th of November 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immage Biotherapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Immage Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Immage Biotherapeutics lagged returns against current returns
Autocorrelation, which is Immage Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immage Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Immage Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Immage Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immage Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immage Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immage Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immage Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Immage Biotherapeutics Lagged Returns
When evaluating Immage Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immage Biotherapeutics stock have on its future price. Immage Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immage Biotherapeutics autocorrelation shows the relationship between Immage Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Immage Biotherapeutics Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Immage Biotherapeutics Correlation, Immage Biotherapeutics Volatility and Immage Biotherapeutics Alpha and Beta module to complement your research on Immage Biotherapeutics. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Immage Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.